Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales Reps Prove Compelling Plaintiffs As Novartis Loses Jury Trial Gamble In Gender Discrimination Case; Pay Policy Could Change Industry-wide

Executive Summary

The jury verdict in the Novartis gender discrimination class action set a precedent that could impact the entire industry. It is the largest verdict ever awarded in such a case - and damages could extend well beyond that $253.4 million awarded so far if other members of the class come forward

You may also be interested in...



Gender Discrimination Suits: Cases Against Pharma Continue Even As Payouts Slow

Novartis will pay $8m to settle second case; last year Daiichi Sankyo settled gender discrimination class action for the same amount and action against Bayer was dismissed following confidential resolution. Cases are ongoing against Merck and Forest.

Novartis Will Track Gender Disparities In Performance Evaluations Under Settlement

Gender discrimination suit is resolved with Novartis paying $175 million, 45 percent less than a jury awarded plaintiffs.

Successful Novartis Sales Reps' Performance Scores Could Be Downgraded To Satisfy Budget Goals, Gender Discrimination Trial Reveals

Former head of human resources testifies at gender discrimination trial that 12 percent of a given employee population had to receive low performance ratings.

Related Content

Topics

UsernamePublicRestriction

Register

SC143384

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel